Exact Mass: 760.3434902

Exact Mass Matches: 760.3434902

Found 50 metabolites which its exact mass value is equals to given mass value 760.3434902, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Mono(glucosyluronic acid)bilirubin

(2S,3S,4S,5R,6S)-6-{[3-(2-{[3-(2-carboxyethyl)-5-{[(2E)-4-ethenyl-5-hydroxy-3-methyl-2H-pyrrol-2-ylidene]methyl}-4-methyl-1H-pyrrol-2-yl]methyl}-5-{[(2Z)-3-ethenyl-5-hydroxy-4-methyl-2H-pyrrol-2-ylidene]methyl}-4-methyl-1H-pyrrol-3-yl)propanoyl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C39H44N4O12 (760.2955584)

This compound belongs to the family of Tricarboxylic Acids and Derivatives. These are organic compounds containing three carboxylic acid groups (or salt/ester derivatives thereof).

Bilirubin glucuronide

(2S,3S,4S,5R,6R)-5-{[3-(2-{[3-(2-carboxyethyl)-5-{[(2Z)-3-ethenyl-4-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene]methyl}-4-methyl-1H-pyrrol-2-yl]methyl}-5-{[(2Z)-4-ethenyl-3-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene]methyl}-4-methyl-1H-pyrrol-3-yl)propanoyl]oxy}-3,4,6-trihydroxyoxane-2-carboxylic acid

C39H44N4O12 (760.2955584)

Bilirubin glucuronide is a natural human metabolite of bilirubin generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. Bilirubin glucuronide is a natural human metabolite of bilirubin generated in the liver by UDP glucuonyltransferase.

(1R,4S,7S,10R,13R,16S)-13-(1H-Indol-3-ylmethyl)-4-(2-methylpropyl)-7-(2-methylsulfanylethyl)-16-(phenylmethyl)-3,6,9,12,15,18,20-heptazabicyclo[8.8.4]docosane-2,5,8,11,14,17,21-heptone

(1R,4S,7S,10R,13R,16S)-13-(1H-indol-3-Ylmethyl)-4-(2-methylpropyl)-7-(2-methylsulphanylethyl)-16-(phenylmethyl)-3,6,9,12,15,18,20-heptazabicyclo[8.8.4]docosane-2,5,8,11,14,17,21-heptone

C38H48N8O7S (760.3366498)

Taxchinin J

C42H48O13 (760.3094758)

Ipomoeassin B

C40H56O14 (760.3669876)

N-Demethylnicaustrine

(+)-N-Demethylnicaustrine

C42H52N2O11 (760.3570922000001)

3-O-{beta-D-galactopyranosyl-(1->2)-[beta-D-glucopyranosyl-(1->6)]-beta-D-glucopyranoside}-5alpha,14alpha-androst-8-ene

C37H60O16 (760.388116)

C38H48O16

C38H48O16 (760.2942208)

C12-beta-glucuronosyl-bilirubin-IX alpha

C39H44N4O12 (760.2955584)

C8-beta-glucuronosyl-bilirubin-IX alpha

C39H44N4O12 (760.2955584)

Bilirubin glucuronate

mono-beta-delta-Glucopyranuronosyl ester 2,17-diethenyl-1,10-19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-biline-8,12-dipropanoic acid

C39H44N4O12 (760.2955584)

LPIM1 18:1

2-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-sn-glycero-3-phospho-1-myo-inositol)

C33H61O17P (760.3646186)

taccalonolide AA

C38H48O16 (760.2942208)

Oxotremorine sesquifumarate

C36H48N4O14 (760.3166868)

Pipecuronium bromide

4,4-((2beta,3alpha,5alpha,16beta,17beta)-3,17-Bis(acetyloxy)androstane-2,16-diyl)bis(1,1-dimethyl-piperazinium) dibromide

C35H62Br2N4O4 (760.3137532)

D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents M - Musculo-skeletal system > M03 - Muscle relaxants > M03A - Muscle relaxants, peripherally acting agents D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant Pipecuronium bromide is a potent long-acting nondepolarizing steroidal neuromuscular blocking agent (NMBA), and a bisquaternary ammonium compound. Pipecuronium bromide is a powerful competitive nAChR antagonist with a Kd of 3.06 μM[1][2][3][4][5].

3-QUINUCLIDINYL XANTHENE-9-CARBOXYLATE H

C44H44N2O10 (760.2995804000001)

2-O-Methyl Uridine CED Phosphoramidite

C40H49N4O9P (760.3236994)

DMT-2'O-Methyl-rU Phosphoramidite (2'-O-Me-U Phosphoramidite) is a 2'-O-Me derivative, and can be used for oligonucleotide synthesis[1][2].

(TETRAHYDRO-PYRAN-2-YL)ACETICACID

C48H48MgN8 (760.3852228)

(1R,4S,7S,10R,13R,16S)-13-(1H-Indol-3-ylmethyl)-4-(2-methylpropyl)-7-(2-methylsulfanylethyl)-16-(phenylmethyl)-3,6,9,12,15,18,20-heptazabicyclo[8.8.4]docosane-2,5,8,11,14,17,21-heptone

(1R,4S,7S,10R,13R,16S)-13-(1H-indol-3-Ylmethyl)-4-(2-methylpropyl)-7-(2-methylsulphanylethyl)-16-(phenylmethyl)-3,6,9,12,15,18,20-heptazabicyclo[8.8.4]docosane-2,5,8,11,14,17,21-heptone

C38H48N8O7S (760.3366498)

(2S,3S,4S,5R,6R)-4-[3-[2-[[3-(2-carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoyloxy]-3,5,6-trihydroxyoxane-2-carboxylic acid

(2S,3S,4S,5R,6R)-4-[3-[2-[[3-(2-carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoyloxy]-3,5,6-trihydroxyoxane-2-carboxylic acid

C39H44N4O12 (760.2955584)

(2S,3S,4S,5R,6R)-4-[3-[2-[[3-(2-carboxyethyl)-5-[(Z)-(4-ethenyl-3-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoyloxy]-3,5,6-trihydroxyoxane-2-carboxylic acid

(2S,3S,4S,5R,6R)-4-[3-[2-[[3-(2-carboxyethyl)-5-[(Z)-(4-ethenyl-3-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoyloxy]-3,5,6-trihydroxyoxane-2-carboxylic acid

C39H44N4O12 (760.2955584)

N-{1-amino-6-[(5-nitro-2-furoyl)amino]-1-oxohexan-2-yl}-23-(indol-3-yl)-20-oxo-4,7,10,13,16-pentaoxa-19-azatricosan-1-amide

C36H52N6O12 (760.3643032)

oct-7-en-1-yl alpha-L-fucopyranosyl-(1->2)-[alpha-D-galactopyranosyl-(1->3)]-beta-D-galactopyranosyl-(1->3)-beta-D-galactopyranoside

C32H56O20 (760.3364776000001)

oct-7-en-1-yl alpha-L-fucopyranosyl-(1->2)-[alpha-D-galactopyranosyl-(1->3)]-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranoside

C32H56O20 (760.3364776000001)

5-aminopentyl alpha-L-rhamnopyranosyl-(1->4)-[beta-L-rhamnopyranosyl-(1->4)-beta-D-glucopyranosyl-(1->3)]-2-acetamido-2-deoxy-beta-D-galactopyranoside

C31H56N2O19 (760.3477106)

mono(glucosyluronic acid)bilirubin

C39H44N4O12 (760.2955584)

LPIM1(18:1(9Z)/0:0)

C33H61O17P (760.3646186)

PI 18:2/9:4;O2

C36H57O15P (760.3434902)

PI 18:4/8:3;O3

C35H53O16P (760.3071067999999)

PI 20:2/8:3;O

C37H61O14P (760.3798735999999)

PI 20:3/7:3;O2

C36H57O15P (760.3434902)

PI 20:4/7:2;O2

C36H57O15P (760.3434902)

PI 20:4/8:1;O

C37H61O14P (760.3798735999999)

PI 22:5/5:1;O2

C36H57O15P (760.3434902)

PI 26:7;O3

C35H53O16P (760.3071067999999)

PI 27:6;O2

C36H57O15P (760.3434902)

PI 28:5;O

C37H61O14P (760.3798735999999)

2,6,8,9-tetrakis(acetyloxy)-4-(benzoyloxy)-3a-(2-hydroxypropan-2-yl)-1,8a-dimethyl-5-methylidene-2h,3h,4h,4ah,6h,7h,8h,9h,10h-cyclohexa[f]azulen-10-yl benzoate

C42H48O13 (760.3094758)

(8r)-8-ethyl-1,6,8,11-tetrahydroxy-10-{[5-({4-hydroxy-5-[(5-hydroxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-6-methyloxan-2-yl]oxy}-7-(hydroxymethyl)-7,9,10,11a-tetrahydro-5ah-tetracene-5,12-dione

(8r)-8-ethyl-1,6,8,11-tetrahydroxy-10-{[5-({4-hydroxy-5-[(5-hydroxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-6-methyloxan-2-yl]oxy}-7-(hydroxymethyl)-7,9,10,11a-tetrahydro-5ah-tetracene-5,12-dione

C39H52O15 (760.3306042)

(7r,8r,10s)-10-{[(2r,4s,5s,6s)-5-{[(2s,5s,6s)-5-{[(2s,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-8-ethyl-1,6,7,8,11-pentahydroxy-9,10-dihydro-7h-tetracene-5,12-dione

(7r,8r,10s)-10-{[(2r,4s,5s,6s)-5-{[(2s,5s,6s)-5-{[(2s,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-8-ethyl-1,6,7,8,11-pentahydroxy-9,10-dihydro-7h-tetracene-5,12-dione

C38H48O16 (760.2942208)